Altundag K - Search Results

1

Colon involvement in a chronic lymphocytic leukemia patient.

Sarici F, Babacan T, Petekkaya I, Gezgen G, Roach EC, Altundag K. Sarici F, et al. Among authors: altundag k. J BUON. 2013 Jan-Mar;18(1):291-2. J BUON. 2013. PMID: 23613420 No abstract available.

2

Acute erythroid leukemia in a patient with chronic lymphocytic leukemia.

Guven DC, Babacan T, Sarici F, Akin S, Altundag K, Turker A. Guven DC, et al. Among authors: altundag k. J BUON. 2014 Oct-Dec;19(4):1127. J BUON. 2014. PMID: 25536628 No abstract available.

3

Impact of inflammatory markers on the prognosis of patients with operable breast cancer.

Petekkaya I, Aksoy S, Roach EC, Okoh AK, Gecmez G, Gezgen G, Isler DC, Dogan E, Babacan T, Sarici F, Petekkaya E, Altundag K. Petekkaya I, et al. Among authors: altundag k. J BUON. 2014 Jul-Sep;19(3):673-80. J BUON. 2014. PMID: 25261651 Free article.

4

Molecular subtypes in patients with inflammatory breast cancer; a single center experience.

Kertmen N, Babacan T, Keskin O, Solak M, Sarici F, Akin S, Arik Z, Aslan A, Ates O, Aksoy S, Ozisik Y, Altundag K. Kertmen N, et al. Among authors: altundag k. J BUON. 2015 Jan-Feb;20(1):35-9. J BUON. 2015. PMID: 25778293 Free article.

5

Prognostic role of inflammatory biomarkers in metastatic breast cancer.

Petekkaya I, Unlu O, Roach EC, Gecmez G, Okoh AK, Babacan T, Sarici F, Keskin O, Arslan C, Petekkaya E, Sever AR, Altundag K. Petekkaya I, et al. Among authors: altundag k. J BUON. 2017 May-Jun;22(3):614-622. J BUON. 2017. PMID: 28730765 Free article.

6

Old school regimen may turn the tide in metastatic breast cancer.

Gezgen G, Roach EC, Kizilarslanoglu MC, Altundag K. Gezgen G, et al. Among authors: altundag k. J BUON. 2011 Oct-Dec;16(4):781. J BUON. 2011. PMID: 22331741 No abstract available.

7

Distribution of breast cancer diagnosis according to month of birth in Turkish population.

Kizilarslanoglu MC, Roach EC, Gezgen G, Altundag K. Kizilarslanoglu MC, et al. Among authors: altundag k. J BUON. 2012 Jan-Mar;17(1):185-6. J BUON. 2012. PMID: 22517717 No abstract available.

8

Metabolic syndrome and breast cancer: an overview.

Gezgen G, Roach EC, Kizilarslanoglu MC, Petekkaya I, Altundag K. Gezgen G, et al. Among authors: altundag k. J BUON. 2012 Apr-Jun;17(2):223-9. J BUON. 2012. PMID: 22740197 Review.

9

Comparison of clinicopathological characteristics and outcome of younger and older breast cancer patients.

Kertmen N, Sahin U, Keskin O, Solak M, Petekkaya I, Babacan T, Sarici F, Arik Z, Kizilarslanoglu B, Altundag K. Kertmen N, et al. Among authors: altundag k. J BUON. 2012 Oct-Dec;17(4):797. J BUON. 2012. PMID: 23335545 No abstract available.

10

Electrolyte abnormalities due to irinotecan administration in metastatic HER-2 positive breast cancer patients.

Petekkaya I, Akin T, Gezgen G, Roach EC, Ozisik Y, Altundag K. Petekkaya I, et al. Among authors: altundag k. J BUON. 2012 Oct-Dec;17(4):800. J BUON. 2012. PMID: 23335549 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

737 results

Search Page

Filters